Digital Diagnostics is honored to have contributed to the impactful conversations at the 2025 NCQA Health Innovation Summit!
The 2025 NCQA Health Innovation Summit brought together healthcare leaders and innovators for three days of collaboration and discussion focused on improving care quality.
The Digital Diagnostics team participated in this year’s event in several ways, including exhibiting at booth #119, where company representatives demonstrated how our FDA-cleared autonomous AI system, LumineticsCore® is:
- Diagnosing diabetic retinopathy (DR) at the point-of-care,
- Helping close care gaps for the eye exam for diabetes (EED)
- Supporting organizations in improving HEDIS, MIPS, and Stars ratings
During a Coffee and Community event, held at our booth, our team had the opportunity to connect with attendees and discuss how AI is positively impacting care gap closure. Conversations with our Commercial team members highlighted how integrating AI into clinical workflows can enhance patient engagement and drive quality improvement.
Key themes from the summit centered on data consistency, value-based care, and the ongoing challenge of aligning payment structures with care delivery priorities. These insights closely reflect Digital Diagnostics’ commitment to leveraging AI-driven solutions that enhance access, close care gaps, and advance quality metrics across healthcare organizations.
As a company committed to advancing accessible, innovative care, we value the opportunity to participate in the NCQA Health Innovation Summit to collaborate with healthcare leaders and reflect on how AI can drive meaningful progress in healthcare quality.
Want to see how one health system is using autonomous AI to close care gaps and improve quality metrics? Watch our webinar to learn how OSF HealthCare implemented LumineticsCore to transform diabetes-related eye exams.